# Once a Day Use of Lactobacillus Casei Shirota on HIV-infected Patients Infected Patients

> **NCT02146027** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 48 (estimated)

## Conditions studied

- HIV

## Interventions

- **DIETARY_SUPPLEMENT:** Fermented Milk Drink Yakult 40
- **DIETARY_SUPPLEMENT:** Fermented Milk Drink Yakult 40

## Key facts

- **NCT ID:** NCT02146027
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2017-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02146027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02146027, "Once a Day Use of Lactobacillus Casei Shirota on HIV-infected Patients Infected Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02146027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*